S&P 500
7,582.20
+0.03%
Dow Jones
51,018.80
+0.58%
Nasdaq 100
30,344.40
+0.25%
Russell 2000
2,916.31
-0.54%
FTSE 100
10,378.60
-0.32%
Nikkei 225
66,231.90
+0.67%

Health and Healthcare

Amazon’s PillPack Purchase Wipes Out $20 Billion in Pharmacy-Related Market Cap

Photo of Paul Ausick
By Paul Ausick Updated Published
This post may contain links from our sponsors and affiliates, and Flywheel Publishing may receive compensation for actions taken through them.
Amazon’s PillPack Purchase Wipes Out $20 Billion in Pharmacy-Related Market Cap

© Thinkstock

Last October, Amazon.com Inc. (NASDAQ: AMZN) was rumored to be getting into the pharmacy business. The stocks of pharmacy retailers dropped 6%. Thursday morning, Amazon announced that it is acquiring PillPack and pharmacy stocks dropped around 9%.

Anytime Amazon takes aim at a new line of business, the old-line participants get the heebie-jeebies. And with good reason: Amazon is widely blamed for forcing brick-and-mortar retailers to close thousands of stores in the past few years.

PillPack is a pharmacy that delivers medications to customers in presorted dose packaging, coordinates refills and renewals, and ensures that shipments are made on time. The deal is expected to close in the second half of this year, but no other details were provided.

Not only does PillPack give Amazon an entry to the pharmacy business, it also serves some of the same functions as pharmacy benefits management (PBM) or distribution companies. Those stocks also took a hit this morning.

[nativounit]

Here’s a look at the impact of Amazon’s announcement on pharmacies and PBMs.

Walgreens Boots Alliance Inc. (NASDAQ: WBA) shares traded down 10.4% at $59.35, after posting a new 52-week low of $59.07 earlier. The 52-week high is $83.89. The company’s market cap dropped by about $7 billion. Walgreens also reported quarterly earnings this morning.

CVS Health Corp. (NYSE: CVS) traded down nearly 9.5%, at $53.45 in a 52-week range of $60.14 to $84.00. The hit to the company’s market cap was around $6.5 billion.

Rite Aid Corp. (NYSE: RAD) traded down nearly 11%, at $1.76 in a 52-week range of $1.38 to $3.12. The company’s market cap dropped by about $180 million.

Diplomat Pharmacy Inc. (NYSE: DPLO) traded down about 5.8% to $25.74. The 52-week range is $28.74 to $14.24. Diplomat’s market cap dropped by about $80 million.

McKesson Corp. (NYSE: MCK) down about 7.5%, at $133.93 after posting a new 52-week low of $131.70. The 52-week high is $1768.86. McKesson’s market cap dropped by nearly $2.7 billion.

Express Scripts Holding Co. (NASDAQ: ESRX) traded down more than 3% to $76.25, in a 52-week range of $55.80 to $85.07. Express Scripts has seen its market cap shrink nearly $1.9 billion.

AmerisourceBergen Corp. (NYSE: ABC) traded down 6.3%, at $84.16 in a 52-week range of $71.90 to $106.27. The company’s market cap has dipped by about $1.2 billion.

Cardinal Health Inc. (NYSE: CAH) traded down 7.8% to $48.83, after posting a new 52-week low of $48.77. The 52-week high is $79.28. Cardinal’s market cap lost nearly $1.4 billion.

[recirclink id=471676]

[wallst_email_signup]

DISCLOSURE:
INVESTMENTS ARE NOT FDIC INSURED • ARE NOT BANK GUARANTEED • MAY LOSE VALUE Brokerage and Active investing products offered through SoFi Securities LLC, member FINRA(www.finra.org)/SIPC(www.sipc.org). Advisory services are offered by SoFi Wealth LLC, an SEC-registered investment adviser. Information about SoFi Wealth’s advisory operations, services, and fees is set forth in SoFi Wealth’s current Form ADV Part 2 (Brochure), a copy of which is available upon request and at www.adviserinfo.sec.gov. Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 30 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Other fees, such as exchange fees, may apply. Please view our fee disclosure to view a full listing of fees. Investing in alternative investments and/or strategies may not be suitable for all investors and involves unique risks, including the risk of loss. An investor should consider their individual circumstances and any investment information, such as a prospectus, prior to investing. Interval Funds are illiquid instruments, the ability to trade on your timeline may be restricted. Brokerage and Active investing products offered through SoFi Securities LLC, Member FINRA(www.finra.org) /SIPC(www.sipc.org). There are limitations with fractional shares to consider before investing. During market hours fractional share orders are transmitted immediately in the order received. There may be system delays from receipt of your order until execution and market conditions may adversely impact execution prices. Outside of market hours orders are received on a not held basis and will be aggregated for each security then executed in the morning trade window of the next business day at market open. Share will be delivered at an average price received for executing the securities through a single batched order. Fractional shares may not be transferred to another firm. Fractional shares will be sold when a transfer or closure request is initiated. Please consider that selling securities is a taxable event. Options involve risks, including substantial risk of loss and the possibility an investor may lose the entire investment Before trading options please review the Characteristics and Risks of Standardized Options  Investing in an Initial Public Offering (IPO) involves substantial risk, including the risk of loss. Further, there are a variety of risk factors to consider when investing in an IPO, including but not limited to, unproven management, significant debt, and lack of operating history. For a comprehensive discussion of these risks please refer to SoFi Securities’ IPO Risk Disclosure Statement This should not be considered a recommendation to participate in IPOs and investors should carefully read the offering prospectus to determine whether an offering is consistent with their investment objectives, risk tolerance, and financial situation. New offerings generally have high demand and there are a limited number of shares available for distribution to participants. Many customers may not be allocated shares and share allocations may be significantly smaller than the shares requested in the customer’s initial offer (Indication of Interest). For more information on the allocation process please visit IPO Allocation.
Follow 24/7 Wall St. on Google
Photo of Paul Ausick
About the Author Paul Ausick →

Paul Ausick has been writing for 247Wallst.com for more than a decade. He has written extensively on investing in the energy, defense, and technology sectors. In a previous life, he wrote technical documentation and managed a marketing communications group in Silicon Valley.

He has a bachelor's degree in English from the University of Chicago and now lives in Montana, where he fishes for trout in the summer and stays inside during the winter.

Continue Reading

Walgreens Replaces GE — as Year’s Worst-Performing Dow Stock
Paul Ausick |

Walgreens Replaces GE — as Year’s Worst-Performing Dow Stock

In addition to taking GE's place on the Dow Jones Industrials index, Walgreens also took over its rank as the…

Paul Ausick |

CVS Beats Estimates, Raises EPS Guidance

ThinkstockCVS Caremark Corp. (NYSE: CVS) reported third-quarter 2012 earnings this morning. The pharmacy benefits management and retail sales firm posted…

Paul Ausick |

Diplomat Turns Bunt Pricing Into Homerun for IPO Buyers

Diplomat Pharmacy priced its IPO shares at $13 on Thursday, but when the stock began trading Friday morning it opened…

Paul Ausick |

Walgreen’s Same-Store Sales Dive

Drug store giant Walgreen Co. (NYSE: WAG) announced this morning that November same-store sales fell 6.2% year-over-year, primarily due to…

9 Companies That Turned Their Fortunes Around in 2018
Evan Comen |

9 Companies That Turned Their Fortunes Around in 2018

2018 has been one of the most volatile years for stocks in recent history. From the start of the year…

Paul Ausick |

Walgreen Stock Jumps on New Deal with Express Scripts

While no details were provided, Walgreen Co. (NYSE: WAG) and Express Scripts Holding Co. (NASDAQ: ESRX) this morning announced a…

Trey Thoelcke |

CVS Caremark Tumbles on Walgreen Deal

CVS Caremark (NYSE: CVS) was down more than 2% in premarket trading Thursday, and its was down more than 5%,…

Paul Ausick |

CVS Profits Rise, Forecast Boosted (CVS, WAG, ESRX)

CVS Caremark Corp. (NYSE: CVS) posted earnings this morning, and EPS rose to $0.81 for the fourth quarter, up from…

Express Scripts Thumped by Short Seller Citron Research
Paul Ausick |

Express Scripts Thumped by Short Seller Citron Research

Around noon on Thursday, short-seller Citron Research offered some free advice to President-Elect Donald Trump: If Trump is serious about…

Top Gaining Stocks

Dell Technologies
DELL • Vol: 42,366,555
NetApp
NTAP • Vol: 15,911,807
ServiceNow
NOW • Vol: 68,243,561
IBM
IBM • Vol: 28,527,546
Hewlett Packard Enterprise
HPE • Vol: 86,996,387

Top Losing Stocks

Coterra Energy
CTRA • Vol: 73,319,495
Clorox
CLX • Vol: 4,744,001
ResMed
RMD • Vol: 3,526,686
Intel
INTC • Vol: 191,680,425
Skyworks Solutions
SWKS • Vol: 5,407,806